Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Sci Rep ; 8(1): 7194, 2018 05 08.
Article in English | MEDLINE | ID: mdl-29740121

ABSTRACT

Pre-clinical research in rodents provides evidence that the central nervous system (CNS) has functional lymphatic vessels. In-vivo observations in humans, however, are not demonstrated. We here show data on CNS lymphatic drainage to cervical lymph nodes in-vivo by magnetic resonance imaging (MRI) enhanced with an intrathecal contrast agent as a cerebrospinal fluid (CSF) tracer. Standardized MRI of the intracranial compartment and the neck were acquired before and up to 24-48 hours following intrathecal contrast agent administration in 19 individuals. Contrast enhancement was radiologically confirmed by signal changes in CSF nearby inferior frontal gyrus, brain parenchyma of inferior frontal gyrus, parahippocampal gyrus, thalamus and pons, and parenchyma of cervical lymph node, and with sagittal sinus and neck muscle serving as reference tissue for cranial and neck MRI acquisitions, respectively. Time series of changes in signal intensity shows that contrast enhancement within CSF precedes glymphatic enhancement and peaks at 4-6 hours following intrathecal injection. Cervical lymph node enhancement coincides in time with peak glymphatic enhancement, with peak after 24 hours. Our findings provide in-vivo evidence of CSF tracer drainage to cervical lymph nodes in humans. The time course of lymph node enhancement coincided with brain glymphatic enhancement rather than with CSF enhancement.


Subject(s)
Arachnoid Cysts/diagnostic imaging , Glymphatic System/diagnostic imaging , Hydrocephalus/diagnostic imaging , Intracranial Hypertension/diagnostic imaging , Intracranial Hypotension/diagnostic imaging , Lymphatic System/diagnostic imaging , Adult , Aged , Arachnoid Cysts/cerebrospinal fluid , Arachnoid Cysts/physiopathology , Cohort Studies , Contrast Media/administration & dosage , Female , Glymphatic System/metabolism , Glymphatic System/physiopathology , Humans , Hydrocephalus/cerebrospinal fluid , Hydrocephalus/physiopathology , Injections, Spinal , Intracranial Hypertension/cerebrospinal fluid , Intracranial Hypertension/physiopathology , Intracranial Hypotension/cerebrospinal fluid , Intracranial Hypotension/physiopathology , Lymph Nodes/diagnostic imaging , Lymph Nodes/metabolism , Lymph Nodes/physiopathology , Lymphatic System/metabolism , Lymphatic System/physiopathology , Lymphatic Vessels/diagnostic imaging , Lymphatic Vessels/metabolism , Lymphatic Vessels/physiopathology , Lymphography , Magnetic Resonance Imaging , Male , Middle Aged , Organometallic Compounds/administration & dosage , Parahippocampal Gyrus/diagnostic imaging , Parahippocampal Gyrus/metabolism , Parahippocampal Gyrus/physiopathology , Parenchymal Tissue/diagnostic imaging , Parenchymal Tissue/metabolism , Parenchymal Tissue/physiopathology , Pons/diagnostic imaging , Pons/metabolism , Pons/physiopathology , Prefrontal Cortex/diagnostic imaging , Prefrontal Cortex/metabolism , Prefrontal Cortex/physiopathology , Thalamus/diagnostic imaging , Thalamus/metabolism , Thalamus/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL